These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1996 related items for PubMed ID: 15086662

  • 1. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB.
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [Abstract] [Full Text] [Related]

  • 2. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees.
    Sławek J, Derejko M, Lass P.
    Parkinsonism Relat Disord; 2005 Nov; 11(7):465-8. PubMed ID: 16154794
    [Abstract] [Full Text] [Related]

  • 3. Apathy and depression in Parkinson disease.
    Oguru M, Tachibana H, Toda K, Okuda B, Oka N.
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):35-41. PubMed ID: 20015839
    [Abstract] [Full Text] [Related]

  • 4. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ.
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [Abstract] [Full Text] [Related]

  • 5. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.
    Neurology; 2005 Nov 08; 65(9):1436-41. PubMed ID: 16275832
    [Abstract] [Full Text] [Related]

  • 6. Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.
    Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A.
    Mov Disord; 2012 Jan 08; 27(1):79-83. PubMed ID: 21915909
    [Abstract] [Full Text] [Related]

  • 7. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F, Bucken-Gobbi LT, Gobbi S, Sant'Ana-Simões C.
    Rev Neurol; 2012 Jan 08; 45(10):594-8. PubMed ID: 18008264
    [Abstract] [Full Text] [Related]

  • 8. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ, CARPA Study Group.
    Neurology; 2008 Jun 03; 70(23):2241-7. PubMed ID: 18519873
    [Abstract] [Full Text] [Related]

  • 9. Comparative responsiveness of Parkinson's disease scales to change over time.
    Schrag A, Spottke A, Quinn NP, Dodel R.
    Mov Disord; 2009 Apr 30; 24(6):813-8. PubMed ID: 19199355
    [Abstract] [Full Text] [Related]

  • 10. The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section.
    Starkstein SE, Merello M.
    Mov Disord; 2007 Nov 15; 22(15):2156-61. PubMed ID: 17721877
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF, Larsen JP, Alves G, Aarsland D.
    Parkinsonism Relat Disord; 2009 May 15; 15(4):295-9. PubMed ID: 18801696
    [Abstract] [Full Text] [Related]

  • 12. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT, Goetz CG.
    Mov Disord; 1998 Jul 15; 13(4):633-6. PubMed ID: 9686766
    [Abstract] [Full Text] [Related]

  • 13. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ, Liu ZG, Gan J, Chen W, Lu LX, Wu JY.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 03; 88(21):1442-5. PubMed ID: 18953846
    [Abstract] [Full Text] [Related]

  • 14. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F, Yekhlef F, Chrysostome V, Balestre E, Quinn NP, Poewe W, Wenning GK.
    Mov Disord; 2002 Jul 03; 17(4):701-9. PubMed ID: 12210859
    [Abstract] [Full Text] [Related]

  • 15. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA, Grosset DG.
    Mov Disord; 2005 May 03; 20(5):616-9. PubMed ID: 15719417
    [Abstract] [Full Text] [Related]

  • 16. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ, Tissingh G, Poels PJ, Zuidema SU, Munneke M, Koopmans RT, Bloem BR.
    J Am Geriatr Soc; 2013 Oct 03; 61(10):1714-21. PubMed ID: 24117286
    [Abstract] [Full Text] [Related]

  • 17. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P, Oakes D, Cui L.
    Mov Disord; 1997 Mar 03; 12(2):183-9. PubMed ID: 9087976
    [Abstract] [Full Text] [Related]

  • 18. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May 03; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 19. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E, Franchignoni F, Pasetti C, Ferriero G, Picco D.
    Neurol Sci; 2003 Oct 03; 24(3):190-1. PubMed ID: 14598081
    [Abstract] [Full Text] [Related]

  • 20. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F.
    Mov Disord; 2005 Jun 03; 20(6):726-33. PubMed ID: 15719426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.